Full Text View
Tabular View
No Study Results Posted
Related Studies
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
This study has been completed.
Study NCT00222170   Information provided by University of Kansas

First Received on September 13, 2005.   Last Updated on May 7, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Esophageal Reflux
Additional conditions recognized in this trial
Esophageal Diseases
Gastroesophageal Reflux
More general conditions related to this trial
Deglutition Disorders
Digestive System Diseases
Esophageal Motility Disorders
Gastrointestinal Diseases
Interventions listed in this trial
Rabeprazole
More general drug interventions related to this trial
Anti-Ulcer Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Kansas
PriCara, Unit of Ortho-McNeil, Inc.
Eisai Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services